Physician profile
Mitzi Taylor
NPI 1346783925
$1,346.28
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $127 · 2022: $117 · 2023: $845 · 2024: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,101.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $406.23 | 2021-2024 | |
| Glaxosmithkline, LLC. | $367.36 | 2022-2023 | Arexvy, Shingrix, Trelegy Ellipta |
| Lilly USA, LLC | $154.52 | 2022-2023 | Mounjaro, Jardiance, Emgality |
| Alkermes, INC. | $124.88 | 2022-2023 | Lybalvi |
| Astrazeneca Pharmaceuticals LP | $97.74 | 2023-2024 | Farxiga, Airsupra |
| Novo Nordisk INC | $72.89 | 2023-2024 | Ozempic, Rybelsus |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $58.75 | 2023-2024 | Xifaxan, Trulance |
| Organon LLC | $28.26 | 2022-2023 | Nexplanon |
| Biohaven Pharmaceuticals, INC. | $16.92 | 2021 | |
| Novartis Pharmaceuticals Corporation | $16.66 | 2022 | |
| Genentech USA, INC. | $2.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitzi Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.